Endocrinology Associates, Inc.

Columbus, Ohio Columbus

2 studies enrolling now · 7 studies all time

What they study most

Acromegaly, Atherosclerotic Cardiovascular Disease, Cortisol Excess, Diabetes Mellitus, Type 2, Obesity, Overweight, Type 1 Diabetes Mellitus, Type 2 Diabetes

Studies at this site

• Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity — Recruiting now
• Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D) — Recruiting now
• A Study to Assess the Safety, Tolerability, and Efficacy of IONIS-GHR-LRx Administered in Patients With Acromegaly — Completed
• A Trial of INS068 in Patients With Type 2 Diabetes Not Adequately Controlled With One or Two Oral Antidiabetics — Completed
• Gan & Lee Insulin Glargine Target Type (2) Evaluating Research — Completed
• Study of Human Plasma-Derived Alpha1-Proteinase Inhibitor in Subjects With New-Onset Type 1 Diabetes Mellitus — Stopped early
• An Open-label, Multi-center, Expanded Treatment Protocol of Pasireotide LAR in Patients With Acromegaly — APPROVED_FOR_MARKETING